Truneura

Reversing Cognitive Decline at Scale

Pioneers in Personalized Lifestyle Medicine have shown that reversing cognitive decline is possible, however the scale and access needed to actually impact the field have been delicate due to the complex nature of the disease, its varied root causes and patient demographic. This groundbreaking event will be hosted by PLMI Founder Dr. Jeffrey Bland to set the stage for the topic. Joining him will be Internationally recognized Neurologist and clinical leader Dale Bredesen, MD who will share not only the critical needs for a root cause approach to reversing cognitive decline, but also the new trends guiding meaningful success. Kristine Burke, MD, the Co-Founder of TruNeura and one of the leading clinicians in the field will discuss her practical implementation and models for scaling her success as well as a pathway for any clinician to build a robust brain health program. If you are interested in this emerging field this is one not to miss.

Join Us for a Groundbreaking Event on Reversing Cognitive Decline

PLMI Founder Dr. Jeffrey Bland and Neurologist Dale Bredesen, MD, will host an event on reversing cognitive decline. Dr. Bredesen will share the need for a root cause approach, while TruNeura Co-Founder Kristine Burke, MD, will discuss practical implementation and scaling success.

This event is a must for those interested in this emerging field.

Date

Mar 04 2025
Expired!

Time

PST
5:00 pm - 7:00 pm

Location

Virtual Free LIVE

Speakers

  • Jeff Bland, PhD
    Jeff Bland, PhD
    Functional Medicine Founder and Pioneer

    Dr. Jeffrey Bland is a personable and highly respected thought leader who has spent more than four decades focused on the improvement of human health.

    He is known worldwide as the founder of the Functional Medicine movement, which represents his vision for a care model that is grounded in systems biology and informed by research that he has a unique ability to synthesize. His pioneering work has created the Personalized Lifestyle Medicine Institute (PLMI), as well as the Institute for Functional Medicine (IFM), the global leader in Functional Medicine education. Since 1991, hundreds of thousands of healthcare practitioners have participated in PLMI and IFM programs, and this collective knowledge has positively impacted the lives of patients all over the world.

  • Dale E. Bredesen, MD
    Dale E. Bredesen, MD
    Senior Director of Precision Brain Health at Pacific Neuroscience Institute® and the Chief Scientific Officer at Apollo Health

    Dale Bredesen, MD, is an internationally recognized neurologist with specialty expertise in the mechanisms of neurodegenerative diseases. He is the Senior Director of Precision Brain Health at Pacific Neuroscience Institute® and the Chief Scientific Officer at Apollo Health.

    Guided by his philosophy and belief that Alzheimer’s disease is not just preventable but reversible, Dr. Bredesen’s innovative research has helped explain the physical mechanism behind the erosion of memory seen in Alzheimer’s disease. His decades of clinical study and neurological research have opened the door to new treatment approaches leading to the ReCODE Protocol™. Also known as the Bredesen Protocol, this methodology has emerged as a viable attempt to prevent, arrest, and reverse symptoms of cognitive decline associated with conditions such as Alzheimer’s disease, dementia, and mild cognitive impairment.

    Dr. Bredesen earned his medical degree from Duke University Medical Center and served as Chief Resident in Neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner’s laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen also directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as founding President and CEO.

    Dr. Bredesen has made significant contributions to medical knowledge and literature, holding over thirty patents to his name. Notably, he put much of his findings and research into the 2017 New York Times Best-Seller, The End of Alzheimer’s.

    Additional book titles include The End of Alzheimer’s Program and The First Survivors of Alzheimer’s, the latter of which presents the stories of seven individuals who reversed their cognitive decline using the ReCODE Protocol, and The Ageless Brain, a revolutionary new approach to preventing the onset of neurodegenerative disease and creating sustained brain health.

  • Kristine Burke, MD
    Kristine Burke, MD
    Founder, Chief Executive, and Medical Director - True Health Center for Precision Medicine, Northern California

    Kristine Burke, MD is a triple board-certified Precision Medicine Physician, Entrepreneur, Author, Educator, and Researcher. She is an expert in the reversal and prevention of chronic diseases such as dementia, diabetes, heart attacks and strokes with a special focus on mold-related illness and its connection to many health conditions. Stemming from her clinical outcomes excellence and research into promoting brain health and reversing the cognitive decline of early dementia and Alzheimer’s Disease, she co-founded TruNeura with its unique AI-supported patient coaching interface and provider-focused clinical decision support software advancing the mission to scale the prevention and reversal of cognitive decline worldwide. To further this mission, she teaches Precision and Functional Medicine to advance the knowledge of other physicians and practitioners in her role as Asst Clinical Professor of Preventive Medicine at Loma Linda University School of Medicine and as an educator and frequent speaker for a variety of national and international organizations.

    She is the Founder, Chief Executive, and Medical Director of True Health Center for Precision Medicine in Northern California – a multi-disciplinary practice that delivers personalized primary care with a proprietary data-driven wellness plan that successfully prevented any heart attacks from occurring among their member patients for over a decade. Always striving to be at the forefront of innovation, her Center was the first commercial site in the US to offer QT Imaging’s Breast Acoustic CT™ Scan that provides remarkable breast imaging quality comfortably, without radiation or compression, offering women a new opportunity to augment their options for breast cancer screening. The Center is proud to provide an array of specialized consultation services to define and address the root causes of disease so that every day they can reverse chronic illness to help people reclaim their health, and their hope.

Sponsor

Go to Top